DiaMedica Therapeutics Inc. (DMAC) Nonoperating Income (Expense) USD 2018 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
DiaMedica Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2023.
  • DiaMedica Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2023 was $709 K, a 210% increase year-over-year.
  • DiaMedica Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was $1.93 M, a 446% increase year-over-year.
  • DiaMedica Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $1.93 M, a 446% increase from 2022.
  • DiaMedica Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $353 K, a 330% increase from 2021.
  • DiaMedica Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $82 K, a 81.1% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $1.93 M $709 K +$480 K +210% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $1.45 M $693 K +$617 K +812% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $832 K $271 K +$258 K +1985% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $574 K $256 K +$221 K +631% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $353 K $229 K +$222 K +3171% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $131 K $76 K +$103 K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $28 K $13 K -$85 K -86.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $113 K $35 K +$31 K +775% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $82 K $7 K -$68 K -90.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 $150 K -$27 K -$155 K -121% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $305 K $98 K -$145 K -59.7% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $450 K $4 K +$16 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $434 K $75 K -$1.13 M -93.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $1.57 M $128 K -$97 K -43.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $1.66 M $243 K +$523 K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $1.14 M -$12 K +$166 K +93.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $975 K $1.21 M +$1.05 M +646% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-10
Q3 2019 -$71 K $225 K +$68 K +43.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$139 K -$280 K -$411 K -314% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $272 K -$178 K -$835 K -127% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $1.11 M $162 K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-23
Q3 2018 $157 K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $131 K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $657 K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.